These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 33479898)
41. Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation. Shen C; He Y; Cheng K; Zhang D; Miao S; Zhang A; Meng F; Miao F; Zhang J Immunol Lett; 2011 Aug; 138(2):144-55. PubMed ID: 21513739 [TBL] [Abstract][Full Text] [Related]
42. Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. Zuñiga E; Motran CC; Montes CL; Yagita H; Gruppi A J Immunol; 2002 Apr; 168(8):3965-73. PubMed ID: 11937553 [TBL] [Abstract][Full Text] [Related]
43. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. Greeneltch KM; Kelly-Welch AE; Shi Y; Keegan AD J Immunol; 2005 Oct; 175(8):4999-5005. PubMed ID: 16210602 [TBL] [Abstract][Full Text] [Related]
46. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis. Xerri L; Devilard E; Hassoun J; Haddad P; Birg F Leukemia; 1997 Nov; 11(11):1868-77. PubMed ID: 9369420 [TBL] [Abstract][Full Text] [Related]
47. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC. Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415 [TBL] [Abstract][Full Text] [Related]
48. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. Zhang H; Yang Y; Horton JL; Samoilova EB; Judge TA; Turka LA; Wilson JM; Chen Y J Clin Invest; 1997 Oct; 100(8):1951-7. PubMed ID: 9329958 [TBL] [Abstract][Full Text] [Related]
49. Protection of T cells from activation-induced cell death by Fas+ B cells. Wang JK; Ju ST; Marshak-Rothstein A Eur J Immunol; 2000 Mar; 30(3):931-7. PubMed ID: 10741411 [TBL] [Abstract][Full Text] [Related]
51. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction. Ju ST; Matsui K; Ozdemirli M Int Rev Immunol; 1999; 18(5-6):485-513. PubMed ID: 10672498 [TBL] [Abstract][Full Text] [Related]
52. Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain. Lückerath K; Kirkin V; Melzer IM; Thalheimer FB; Siele D; Milani W; Adler T; Aguilar-Pimentel A; Horsch M; Michel G; Beckers J; Busch DH; Ollert M; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Staal FJ; Rajalingam K; Hueber AO; Strobl LJ; Zimber-Strobl U; Zörnig M Blood; 2011 Jan; 117(2):519-29. PubMed ID: 20971954 [TBL] [Abstract][Full Text] [Related]
53. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. Kauma SW; Huff TF; Hayes N; Nilkaeo A J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730 [TBL] [Abstract][Full Text] [Related]
54. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells. Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023 [TBL] [Abstract][Full Text] [Related]
55. Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway. Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Fujimoto J; Kakishita E Immunology; 2000 Jan; 99(1):94-100. PubMed ID: 10651946 [TBL] [Abstract][Full Text] [Related]
56. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Dotti G; Savoldo B; Pule M; Straathof KC; Biagi E; Yvon E; Vigouroux S; Brenner MK; Rooney CM Blood; 2005 Jun; 105(12):4677-84. PubMed ID: 15713795 [TBL] [Abstract][Full Text] [Related]
57. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840 [TBL] [Abstract][Full Text] [Related]
58. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis. Wei Y; Chen K; Sharp GC; Braley-Mullen H J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889 [TBL] [Abstract][Full Text] [Related]
59. Soluble Fas ligand is associated with natural killer cell dynamics in coronary artery disease. Szymanowski A; Li W; Lundberg A; Evaldsson C; Nilsson L; Backteman K; Ernerudh J; Jonasson L Atherosclerosis; 2014 Apr; 233(2):616-622. PubMed ID: 24534457 [TBL] [Abstract][Full Text] [Related]
60. A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection. Bień K; Sobańska Z; Sokołowska J; Bąska P; Nowak Z; Winnicka A; Krzyzowska M Arch Virol; 2016 Apr; 161(4):913-28. PubMed ID: 26780774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]